Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau announces Health Canada Authorization for Alpha DaRT clinical trial for the treatment of liver metastases

JERUSALEM, March 01, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has received authorization from Health Canada to proceed with a feasibility and safety study of Alpha DaRT in the treatment of liver metastases, subject to final approval by an institutional Research Ethics Board, which the Company expects to receive in the coming weeks. The study is planned to be conducted at the McGill University Health Center in Montreal, Canada. Read...

Read More

[Greenlight in Business Wire] Greenlight announces industry-first employee benefit program to improve financial wellness for families in the workplace

ATLANTA–(BUSINESS WIRE)–Greenlight® Financial Technology, Inc. (“Greenlight”), the fintech company on a mission to help parents raise financially-smart, independent kids, today announced Greenlight for Work — a benefit program for employers to help working parents teach their kids about money and improve financial literacy for the whole family. Read more...

Read More